p38α inhibitor 1
Based on 1 Customer Validation
p38α inhibitor 1 (Arry-797) is a p38α inhibitor. p38α inhibitor 1 is applicable to research related to diseases including Alzheimer's disease and inflammatory dilated cardiomyopathy.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98.91%
- CAS. Nr.: 1034189-82-6
- Formel: C22H26F2N4O2
- Molecular Weight:416.46
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
HY-10256
Adezmapimodp38 MAPK Inhibitor -
HY-10295
SB 202190p38 MAPK Inhibitor -
HY-10320
Doramapimodp38 MAPK Inhibitor -
HY-10578
PD 169316p38 MAP Kinase Inhibitor -
HY-10256A
Adezmapimod hydrochloridep38 MAPK Inhibitor -
HY-10328
Neflamapimodp38α Inhibitor -
HY-10402
Losmapimodp38α/β MAPK Inhibitor -
HY-11068
SB 239063p38 MAPK Inhibitor -
HY-16782
PexmetinibTie-2/p38 MAPK Inhibitor -
HY-10403
PH-797804p38α/β Inhibitor -
HY-10456
TAK-715p38 MAPK Inhibitor -
HY-18850
MAPK13-IN-1MPAK13 Inhibitor
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
p38α |
In Vitro
p38α is a classic mitogen-activated protein kinase that governs the processes of inflammatory stress, cell apoptosis and fibrosis, and serves as a promising target for anti-inflammatory and anti-fibrotic therapies.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 1034189-82-6
-
Appearance Solid
-
Molecular Weight 416.46
-
Formel C22H26F2N4O2
-
Color White to off-white
-
SMILES
O=C(C1=CC2=C(C=C1OC3=CC=C(F)C=C3F)C=NN2CC(C)C)NCCN(C)C
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : ≥ 125 mg/mL (300.15 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (4.99 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (4.99 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (274 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.4012 mL | 12.0060 mL | 24.0119 mL | 60.0298 mL |
| 5 mM | 0.4802 mL | 2.4012 mL | 4.8024 mL | 12.0060 mL | |
| 10 mM | 0.2401 mL | 1.2006 mL | 2.4012 mL | 6.0030 mL | |
| 15 mM | 0.1601 mL | 0.8004 mL | 1.6008 mL | 4.0020 mL | |
| 20 mM | 0.1201 mL | 0.6003 mL | 1.2006 mL | 3.0015 mL | |
| 25 mM | 0.0960 mL | 0.4802 mL | 0.9605 mL | 2.4012 mL | |
| 30 mM | 0.0800 mL | 0.4002 mL | 0.8004 mL | 2.0010 mL | |
| 40 mM | 0.0600 mL | 0.3001 mL | 0.6003 mL | 1.5007 mL | |
| 50 mM | 0.0480 mL | 0.2401 mL | 0.4802 mL | 1.2006 mL | |
| 60 mM | 0.0400 mL | 0.2001 mL | 0.4002 mL | 1.0005 mL | |
| 80 mM | 0.0300 mL | 0.1501 mL | 0.3001 mL | 0.7504 mL | |
| 100 mM | 0.0240 mL | 0.1201 mL | 0.2401 mL | 0.6003 mL |
p38α inhibitor 1 Related Classifications
HY-114423 Related Classifications
Powered by Bioz
Keywords
- p38α inhibitor 1
- 1034189-82-6
- p38 MAPK
- dementias
- alzheimer's disease
- inflammatory dilated cardiomyopathy
- p38α mitogen-activated protein kinase
- inflammatory bowel disease
- butyrylcholinesterase
- acute coronary syndrome
- atherosclerosis
- neurodegenerative conditions
- chronic airway inflammatory diseases
- Inhibitor
- inhibitor
- inhibit